Drug Pipeline

Pyrazinamide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-19 NCT07595042 A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06253715 Shortened Regimen for Drug-susceptible TB in Children Tuberculosis Recruiting
Phase 2
NCT06192160 Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis Pulmonary Tuberculosis Recruiting
NCT05383742 Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and… Tuberculous Meningitis Recruiting
NCT05556746 Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard… Tuberculosis, Pulmonary Active, Not Recruiting
NCT07595042 A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) Tuberculosis Not Yet Recruiting
Sponsors Running Pyrazinamide Trials
National Institute of Allergy and Infectious Diseases (NIAID) (3) Brigham and Women's Hospital (1) Johns Hopkins University (1)
Get alerts when Pyrazinamide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free